Open AccessProgressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene Expression
Author(s) -
Patricia J. Simner,
Heba H. Mostafa,
Yehudit Bergman,
Michael Ante,
Tsigereda Tekle,
Ayomikun Adebayo,
Stephan Beisken,
Kathryn Dzintars,
Pranita D. Tamma
Publication year - 2021
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab888
Subject(s) - escherichia coli , medicine , gene , gene expression , microbiology and biotechnology , genetics , biology
As cefiderocol is increasingly being prescribed in clinical practice, it is critical that we understand key mechanisms contributing to acquired resistance to this agent.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom